Importancia de los genes fur y thyA en la patogenia de Haemophilus parasuis

Consultable des del TDXTítol obtingut de la portada digitalitzadaHaemophilus parasuis es un miembro de la familia Pasteurellaceae y un importante patógeno del tracto respiratorio porcino, causante de la enfermedad de Glässer. En la actualidad, esta enfermedad es una de las que tiene mayor incidencia en el sector porcino con una elevada repercusión económica. Por este motivo, es necesario estudiar la biología molecular de este patógeno para poder desarrollar vacunas más eficientes que las existentes hasta el presente. Para abordar dicho estudio es imprescindible disponer de algún proceso de transferencia genética eficaz en H. parasuis. No obstante, dado el desconocimiento que se tenía de dicho patógeno, no se conocía ningún mecanismo natural o de laboratorio que permitiera introducir DNA en H. parasuis. Por ello, el primer objetivo del presente trabajo ha sido desarrollar un método de transferencia genética en H. parasuis que permita estudiar posteriormente los genes implicados en su virulencia y en la colonización del hospedador. En la presente tesis se ha demostrado por vez primera que H. parasuis es capaz de transformar de forma natural si el DNA exógeno contiene la secuencia ACCGAACTC, la cual es muy similar al motivo ACCGCACTT descrito en H. influenzae como Uptake Signal Sequence. Además, se ha optimizado este proceso, determinando las concentraciones más adecuadas de células bacterianas, AMPc y DNA transformante, así como el tiempo de incubación. Un segundo objetivo de este trabajo ha sido averiguar el papel de la timidilato sintasa, enzima clave en la síntesis de desoxitimidina monofosfato (dTMP), en la virulencia de H. parasuis. Para ello, se ha construido un mutante knockout en el gen thyA de H. parasuis y se ha determinado la capacidad de colonización y la inmunogeniciad de la cepa salvaje y de dicho mutante thyA en un modelo animal de cobayas. Los resultados han mostrado que la cepa defectiva en la enzima timidilato sintasa tienen una menor capacidad de colonización, a pesar de que es capaz de inducir una respuesta inmune en el animal. Por ello, el mutante thyA de H. parasuis puede ser un buen candidato para el desarrollo de futuras vacunas. Finalmente, en este trabajo se ha estudiado la importancia de la proteína Fur en la virulencia de H. parasuis. Dicha proteína es un regulador pleiotrópico que, entre otras funciones, controla los mecanismos implicados en la captación de hierro. Para abordar esta parte del trabajo se propuso la construcción de un mutante de H. parasuis defectivo en la proteína Fur. Los resultados obtenidos han mostrado claramente que dicha proteína es esencial para la viabilidad de esta bacteria. Así, se ha determinado el entorno genético del gen fur y se ha confirmado la no viabilidad de los mutantes fur mediante la obtención de cepas merodiploides.Haemophilus parasuis, is a member of the family Pasteurellaceae and an important respiratory-tract pathogen of swine, which is the etiological agent of Glässer's disease. At present, the H. parasuis infections produce significant mortality and morbidity in pig farms, giving rise to important economic losses in this industry. For this reason, it is necessary to study the molecular biology of this pathogen to develop vaccines more efficient. Because no genetic manipulation system is available for H. parasuis so far, the first objective of this work was to develop a method of gene transfer to study the genes involved in virulence of this organism. In this work has been demonstrated for the first time that H. parasuis is capable of transforming exogenous DNA which contains ACCGAACTC sequence. This sequence is very similar to the motive ACCGCACTT described in H. influenzae as Uptake Signal Sequence. In addition, this process has been optimized, determining the most appropriate concentrations of bacterial cells, cAMP and transforming DNA, as well as the incubation time. A second objective of this study was to determine the role of thymidylate synthase enzyme in the virulence of H. parasuis. This enzyme is essential for dTMP synthesis and, consequently, for DNA replication. To do so, a H. parasuis thyA mutant was constructed in order to analyze its colonization characteristics and its capacity to generate serum bactericidal activity in infected guinea pigs. The data showed that colonization by the H. parasuis thyA mutant was much less than that of the wild-type strain. Nevertheless, the mutant generated a strong immunogenic response similar to the wild-type strain. Therefore, the H. parasuis thyA mutant can be a good candidate to develop future vaccines. Finally, this work has studied the importance of the Fur protein in the virulence of H. parasuis. This protein is a global regulator which, among other duties, controls the mechanisms involved in iron uptake. To perform this part of the study was proposed the construction of a H. parasuis fur mutant. The results have clearly shown that this protein is essential for the viability of this bacterium. Thus, it has been determined the genetic surrounding of fur gene and has confirmed the non-viability of fur mutants by obtaining H. parasuis fur-defective merodiploid strains

Paral·lelisme entre el mètode Halal i el mètode convencional de sacrifici de xais a l'escorxador

Treball presentat a l'assignatura de Deontologia i Veterinària Legal (21223

Colonization capacity and serum bactericidal activity of Haemophilus parasuis thy mutants

The bacterial thyA gene encodes the enzyme thymidylate synthase, which is essential for dTMP synthesis and, consequently, for DNA replication. In this work, a Haemophilus parasuis thyA mutant was constructed in order to analyze its colonization characteristics and its capacity to generate serum bactericidal activity in infected guinea pigs. The data showed that colonization by the H. parasuis thyA mutant was much less than that of the wild-type strain. Nevertheless, the mutant generated a strong immunogenic response in the host, as detected by measuring serum bactericidal activity. [Int Microbiol 2006; 9(4):297-301

Using pluripotent stem cells to understand normal and leukemic hematopoietic development

Several decades have passed since the generation of the first embryonic stem cell (ESC) lines both in mice and in humans. Since then, stem cell biologists have tried to understand their potential biological and clinical uses for their implementation in regenerative medicine. The hematopoietic field was a pioneer in establishing the potential use for the development of blood cell products and clinical applications; however, early expectations have been truncated by the difficulty in generating bonafide hematopoietic stem cells (HSCs). Despite some progress in understanding the origin of HSCs during embryonic development, the reproduction of this process in vitro is still not possible, but the knowledge acquired in the embryo is slowly being implemented for mouse and human pluripotent stem cells (PSCs). In contrast, ESC-derived hematopoietic cells may recapitulate some leukemic transformation processes when exposed to oncogenic drivers. This would be especially useful to model prenatal leukemia development or other leukemia-predisposing syndromes, which are difficult to study. In this review, we will review the state of the art of the use of PSCs as a model for hematopoietic and leukemia development

Control by Fur of the nitrate respiration regulators NarP and NarL in Salmonella enterica

Anaerobic metabolism is controlled by several transcriptional regulators, including ArcA, Fnr, NarP, and NarL, with the Fnr and ArcA proteins sensitive to the cell’s redox status. Specifically, the two-component ArcAB system is activated in response to the oxidation state of membrane-bound quinones, which are the central electron carriers of respiration. Fnr, by contrast, directly senses cellular oxidation status through the [4Fe-4S] cluster present in its own structure. In this study, a third additional redox-associated pathway that controls the nitrate respiration regulators NarL and NarP was identified. The results showed that, in Salmonella enterica, the expression of these two transcriptional regulators is under the control of Fur, a metalloregulator that senses the presence of Fe2+ and regulates the homeostasis of this cation inside the cell. Thus, the Fur- Fe2+ complex increases the expression of narL and represses that of narP. Furthermore, studies of S. enteric mutants defective in the Fur-regulated sRNA RfrA and RfrB showed that those sRNA control both narP and narL expression. These results confirm Fur as a global regulator based on its involvement not only in iron uptake and detoxification but also in the control of nitrate/nitrite respiration by sensing cellular redox status. [Int Microbiol 2010; 13(1):33-39

Heterologous protective immunization elicited in mice by Pasteurella multocida fur ompH

Different strategies have been developed to produce vaccines against Pasteurella multocida. The approach described herein involves overexpression on the bacterial cell surface of Fur-regulated IROMPs (iron-regulated outer-membrane proteins). Accordingly, the ability of fur mutants to promote heterologous protection was examined in a Swiss mouse animal model. Two fur mutants derived from P. multocida were isolated, one of which was also defective in the OmpH protein. In mice challenged with virulent P. multocida, outer-membrane protein (OMP) extracts of fur cells conferred the same protection as obtained with wild-type cells grown in iron-depleted medium. Total protection was achieved with 40 μg of OMP extract from the fur ompH mutant. Mice administered heat-inactivated fur ompH cells were 60% cross-protected. The presence of a galE mutation in these cells did not further increase the protection level. Additionally, cell disruption by sonication provoked a higher level of protection than conferred by heat-treated cells. Taken together, the results showed that P. multocida fur ompH cells offer a simple and suitable approach for cross-protecting animals against infection with P. multocida. [Int Microbiol 2008; 11(1):17-24

GATA2 deficiency and MDS/AML: experimental strategies for disease modelling and future therapeutic prospects

The importance of predisposition to leukaemia in clinical practice is being increasingly recognized. This is emphasized by the establishment of a novel WHO disease category in 2016 called 'myeloid neoplasms with germline predisposition'. A major syndrome within this group is GATA2 deficiency, a heterogeneous immunodeficiency syndrome with a very high lifetime risk to develop myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). GATA2 deficiency has been identified as the most common hereditary cause of MDS in adolescents with monosomy 7. Allogenic haematopoietic stem cell transplantation is the only curative option; however, chances of survival decrease with progression of immunodeficiency and MDS evolution. Penetrance and expressivity within families carrying GATA2 mutations is often variable, suggesting that co-operating extrinsic events are required to trigger the disease. Predictive tools are lacking, and intrafamilial heterogeneity is poorly understood; hence there is a clear unmet medical need. On behalf of the ERAPerMed GATA2 HuMo consortium, in this review we describe the genetic, clinical, and biological aspects of familial GATA2-related MDS, highlighting the importance of developing robust disease preclinical models to improve early detection and clinical decision-making of GATA2 carriers

Deficiency in p53 is required for doxorubicin induced transcriptional activation of NF-кB target genes in human breast cancer

NF-кB has been linked to doxorubicin resistance in breast cancer patients. NF- кB nuclear translocation and DNA binding in doxorubicin treated-breast cancer cells have been extensively examined; however its functional relevance at transcriptional level on NF-кB -dependent genes and the biological consequences are unclear. We studied NF-кB -dependent gene expression induced by doxorubicin in breast cancer cells and fresh human cancer specimens with different genetic backgrounds focusing on their p53 status. NF-кB –dependent signature of doxorubicin was identified by gene expression microarrays in breast cancer cells treated with doxorubicin and the IKKβ-inhibitor MLN120B, and confirmed ex vivo in human cancer samples. The association with p53 was functionally validated. Finally, NF-кB activation and p53 status was determined in a cohort of breast cancer patients treated with adjuvant doxorubicin-based chemotherapy. Doxorubicin treatment in the p53-mutated MDA-MB-231 cells resulted in NF NF- кB driven-gene transcription signature. Modulation of genes related with invasion, metastasis and chemoresistance (ICAM-1, CXCL1, TNFAIP3, IL8) were confirmed in additional doxorubicin-treated cell lines and fresh primary human breast tumors. In both systems, p53-deficient background correlated with the activation of the NF-кB –dependent signature. Furthermore, restoration of p53WT in the mutant p53 MDAMB- 231 cells impaired NF-кB driven transcription induced by doxorubicin. Moreover, a p53 deficient background and nuclear NF-кB /p65 in breast cancer patients correlated with reduced disease free-survival. This study supports that p53 deficiency is necessary for a doxorubicin driven NF-кB -response that limits doxorubicin cytotoxicity in breast cancer and is linked to an aggressive clinical behavior.Financial support: This work was supported by RD12/0036/0051 (J.A.), RD09/0076/0101, RD09/0076/0036, RD12/0036/0054 (A.B), RD12/0036/0070 (A. Ll), PI12/00680 (J.A.), PI12/01552 (F.R.), PI12/01421 (A.Ll.), 2009 SGR 321 (J.A.), FMM 9757/002 (F.R.), and the “Xarxa de Bancs de tumors sponsored by Pla Director d’Oncologia de Catalunya (XBTC). J.A. and F.R. are recipients of intensification program ISCIII/FEDER. We thank Fundació Cellex (Barcelona) for a generous donation to the Hospital del Mar Medical Oncology Service. We thank Millenium for generously providing MLN120B

Genomics improves risk stratifi cation of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials

Genetic information has been crucial to understand the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL) at diagnosis and at relapse, but still nowadays has a limited value in a clinical context. Few genetic markers are associated with the outcome of T-ALL patients, independently of measurable residual disease (MRD) status after therapy. In addition, the prognostic relevance of genetic features may be modulated by the specific treatment used. We analyzed the genetic profile of 145 T-ALL patients by targeted deep sequencing. Genomic information was integrated with the clinical -biological and survival data of a subset of 116 adult patients enrolled in two consecutive MRD-oriented trials of the Spanish PETHEMA (Programa Espanol de Tratamientos en Hematologia) group. Genetic analysis revealed a mutational profile defined by DNMT3A/ N/KRAS/ MSH2/ U2AF1 gene mutations that identified refractory/resistant patients. Mutations in the DMNT3A gene were also found in the non-leukemic cell fraction of patients with T-ALL, revealing a possible mutational-driven clonal hematopoiesis event to prime T-ALL in elderly. The prognostic impact of this adverse genetic profile was independent of MRD status on day +35 of induction therapy. The combined worse-outcome genetic signature and MRD on day +35 allowed risk stratification of T-ALL into standard or high-risk groups with significantly different 5 -year overall survival (OS) of 52% (95% confidence interval: 37-67) and 17% (95% confidence interval: 1-33), respectively. These results confirm the relevance of the tumor genetic profile in predicting patient outcome in adult T-ALL and highlight the need for novel gene-targeted chemotherapeutic schedules to improve the OS of poor-prognosis T-ALL patients

Prostate tumor OVerexpressed-1 (PTOV1) down-regulates HES1 and HEY1 notch targets genes and promotes prostate cancer progression

Background PTOV1 is an adaptor protein with functions in diverse processes, including gene transcription and protein translation, whose overexpression is associated with a higher proliferation index and tumor grade in prostate cancer (PC) and other neoplasms. Here we report its interaction with the Notch pathway and its involvement in PC progression. Methods Stable PTOV1 knockdown or overexpression were performed by lentiviral transduction. Protein interactions were analyzed by co-immunoprecipitation, pull-down and/or immunofluorescence. Endogenous gene expression was analyzed by real time RT-PCR and/or Western blotting. Exogenous promoter activities were studied by luciferase assays. Gene promoter interactions were analyzed by chromatin immunoprecipitation assays (ChIP). In vivo studies were performed in the Drosophila melanogaster wing, the SCID-Beige mouse model, and human prostate cancer tissues and metastasis. The Excel package was used for statistical analysis [...]